24 October 2024 - The Department of Health and Aged Care has received notification that pharmaceutical companies plan to bring ...
26 March 2024 - PDUFA date set for 24 September 2024. ...
5 October 2022 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
12 September 2022 - We compare and contrast the submissions nominated by the PBAC in March for an early re-entry ...
31 March 2022 - NDA submission for Polarean’s hyperpolarised 129Xenon gas drug device combination product ...
21 January 2022 - On 30 August 2021, the National Medicines Policy Review Committee invited submissions to support the Review of ...
9 July 2021 - PHARMAC is starting its funding assessment process for a new cystic fibrosis medication after receiving an ...
6 July 2021 - Agenda revised on the eve of next scheduled meeting. ...
28 December 2020 - Marketing authorisation application is supported by positive results from the pivotal Phase 3 True North trial evaluating ...
14 November 2019 - The Department of Health (the Department) has been working to digitise and simplify the PBS submission ...
25 July 2019 - From 1 August 2019, hospital authorities will no longer be required to seek separate approval from ...
14 May 2019 - The list includes a number of medicines for patients with breast cancer. ...
27 February 2019 - Bayer today announced the completion of the rolling submission of a new drug application for darolutamide to ...
7 January 2019 - The PBAC considered 195 submissions in 2018; 173 were considered by the PBAC in 2017. ...
3 May 2018 - New Zealand infants suffering from a rare neuromuscular condition may soon be eligible for compassionate access ...